XML 12 R2.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 67,894 $ 86,952
Accounts receivable, net 47,454 47,682
Inventories 10,026 12,158
Prepaid expenses 3,452 3,349
Other current assets 2,892 1,201
Total current assets 131,718 151,342
Property and equipment, net 3,254 3,222
Operating lease right-of-use assets 6,922 7,185
Intangible assets, net 49,359 48,754
Goodwill 21,208 21,208
Other assets 900 858
Total assets 213,361 232,569
Current liabilities    
Accounts payable 16,176 9,236
Accrued expenses 26,619 40,791
Operating lease liabilities 1,967 1,718
Contingent royalty obligation payable to Evolus Founders 11,471 11,215
Total current liabilities 56,233 62,960
Operating lease liabilities 6,427 6,755
Contingent royalty obligation payable to Evolus Founders 33,080 33,550
Term loan, net of discount and issuance costs 121,807 121,506
Contingent milestone payment 2,416 2,270
Deferred tax liability 2 6
Total liabilities 219,965 227,047
Commitments and contingencies (Note 9)
Stockholders’ equity (deficit)    
Preferred stock, $0.00001 par value; 10,000,000 shares authorized; no shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 0 0
Common stock, $0.00001 par value; 100,000,000 shares authorized; 64,448,820 and 63,497,548 shares issued and outstanding at March 31, 2025 and December 31, 2024, respectively 1 1
Additional paid-in capital 622,525 615,825
Accumulated other comprehensive loss (839) (905)
Accumulated deficit (628,291) (609,399)
Total stockholders’ equity (deficit) (6,604) 5,522
Total liabilities and stockholders’ equity (deficit) $ 213,361 $ 232,569